Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Influenza A Virus Non-Structural Protein 1, N-His and C-Myc

Cat. No.VG9C17

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Influenza A Virus Non-Structural Protein 1, N-His and C-Myc is a recombinant protein expressed from E.coli. Its predicted molecular weight is 34.3 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 34.3 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 6% Trehalose.

Target Information

Influenza A virus non-structural protein 1 (NS1) is a multifunctional protein that counteracts host immune responses and facilitates viral replication. It binds to and inhibits host cell mRNA processing, evading antiviral mechanisms. In veterinary medicine, NS1's role is pivotal for understanding viral pathogenesis and developing strategies for disease control and vaccine design in avian and swine influenza.

Protein Influenza A Virus Non-Structural Protein 1 (NS)
Protein Synonym NS1A
Gene ID 8656648
UniProt ID P03494

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

References

  1. Marsili, Giulia. et al. Identification of anti-influenza A compounds inhibiting the viral non-structural protein 1 (NS1) using a type I interferon-driven screening strategy. International Journal of Molecular Sciences. 2023. 24.13: 10495.
Inquiry Basket